Shenker B J, Vitale L A, Welham D A
Department of Pathology, University of Pennsylvania School of Dental Medicine, Philadelphia 19104-6002.
Infect Immun. 1990 Dec;58(12):3856-62. doi: 10.1128/iai.58.12.3856-3862.1990.
Actinobacillus actinomycetemcomitans produces an immunosuppressive factor (ISF) which has been shown to suppress mitogen- and antigen-induced DNA, RNA, and protein synthesis in human T lymphocytes. In this study, we examined purified A. actinomycetemcomitans ISF for its ability to alter immunoglobulin production by human B cells. The ISF caused a dose-dependent inhibition of pokeweed mitogen (PWM)-induced immunoglobulin G (IgG) and IgM production. Preexposure to ISF was not required to achieve maximal inhibition of immunoglobulin synthesis, as previously observed for its effect on T-cell activation. Nevertheless, the ISF appeared to act by irreversibly affecting the early stages of cell activation. While PWM-induced immunoglobulin production is under the influence of T-regulatory circuits, it appears that the ISF interacts directly with B cells. First, ISF failed to alter either the synthesis of interleukin-2 (IL-2) or the expression of IL-2 receptors on T cells. Second, experiments in which individual purified populations of cells were exposed to ISF, washed, and placed back into tissue culture indicated that when all cells (i.e., T cells, B cells, and monocytes) were exposed to ISF, significant suppression was observed. However, when only one cell population was treated with ISF, suppression of both IgG and IgM synthesis was observed only when the B-cell-enriched population was exposed to ISF. These results in conjunction with our earlier findings suggest that the ISF functions via the activation of a regulatory subpopulation of B lymphocytes, which in turn either directly or indirectly (via suppressor T cells) downregulate both B- and T-cell responsiveness. Furthermore, it is hypothesized that patients who harbor A. actinomycetemcomitans could suffer from local or systemic immune suppression. This suppression may enhance the pathogenicity of A. actinomycetemcomitans itself or that of some other opportunistic organism.
伴放线放线杆菌可产生一种免疫抑制因子(ISF),该因子已被证明能抑制人T淋巴细胞中由丝裂原和抗原诱导的DNA、RNA及蛋白质合成。在本研究中,我们检测了纯化的伴放线放线杆菌ISF对人B细胞免疫球蛋白产生的影响。ISF对商陆丝裂原(PWM)诱导的免疫球蛋白G(IgG)和IgM产生具有剂量依赖性抑制作用。与之前观察到的其对T细胞活化的作用不同,实现免疫球蛋白合成的最大抑制并不需要预先接触ISF。然而,ISF似乎通过不可逆地影响细胞活化的早期阶段发挥作用。虽然PWM诱导免疫球蛋白的产生受T调节回路影响,但ISF似乎直接与B细胞相互作用。首先,ISF未能改变白细胞介素-2(IL-2)的合成或T细胞上IL-2受体表达。其次,将单个纯化的细胞群体暴露于ISF、洗涤后再放回组织培养中的实验表明,当所有细胞(即T细胞、B细胞和单核细胞)都暴露于ISF时,可观察到显著抑制。然而当仅一个细胞群体用ISF处理时,仅当富含B细胞群体暴露于ISF时才观察到IgG和IgM合成的抑制作用。这些结果与我们早期的发现共同表明,ISF通过激活B淋巴细胞的一个调节亚群发挥作用,该亚群进而直接或间接(通过抑制性T细胞)下调B细胞和T细胞的反应性。此外,据推测,携带伴放线放线杆菌的患者可能会出现局部或全身免疫抑制。这种抑制可能会增强伴放线放线杆菌本身或其他一些机会性生物体的致病性。